Regeneron Pharmaceuticals, Inc.

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2021, 2019, 2016

Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

⚡
Renewable Energy
22%
of total energy
⚙️
Energy Use
6.6K MWh (added)
2023

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
201994.0K tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • By 2025, reduce combined Scope 1 and 2 (market-based) GHG emissions per square meter by 30% based on a 2016 peak baseline.
  • By 2025, invest in the production of renewable power to meet long-term electricity needs.
  • By 2025, match 50% of electricity consumption with electricity from certified renewable energy sources.
  • By 2025, develop and implement waste management plans to further increase plastic recycling and reduce hazardous waste generation.
  • By 2025, improve water efficiencies by implementing a global water mapping strategy and water stewardship program.

🔭 Long-term

  • By 2035, match 100% of electricity consumption with electricity from certified renewable energy sources.

🌱 ESG Focus Areas

Improving the Lives of People with Serious DiseasesFostering a Culture of Integrity & ExcellenceBuilding Sustainable Communities

⚠️ Challenges & Risks +

  • Refining climate action plan to reflect growing business and changes to science-based targets criteria.
  • Small amount of non-hazardous waste disposed via landfill at two non-manufacturing sites.

📋 Report Information

Reporting Period: 2023
Frameworks: UN SDGs, CDP Supply Chain